Cargando…

Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation

Atrial fibrillation (AF) is associated with an increased risk of stroke, which can be prevented by the use of oral anticoagulation. Although non-vitamin K antagonist oral anticoagulants (NOACs) have become the first choice for stroke prevention in the majority of patients with non-valvular AF, adher...

Descripción completa

Detalles Bibliográficos
Autores principales: Farinha, José Maria, Jones, Ian D, Lip, Gregory Y H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850710/
https://www.ncbi.nlm.nih.gov/pubmed/35185408
http://dx.doi.org/10.1093/eurheartj/suab152
_version_ 1784652659606683648
author Farinha, José Maria
Jones, Ian D
Lip, Gregory Y H
author_facet Farinha, José Maria
Jones, Ian D
Lip, Gregory Y H
author_sort Farinha, José Maria
collection PubMed
description Atrial fibrillation (AF) is associated with an increased risk of stroke, which can be prevented by the use of oral anticoagulation. Although non-vitamin K antagonist oral anticoagulants (NOACs) have become the first choice for stroke prevention in the majority of patients with non-valvular AF, adherence and persistence to these medications remain suboptimal, which may translate into poor health outcomes and increased healthcare costs. Factors influencing adherence and persistence have been suggested to be patient-related, physician-related, and healthcare system-related. In this review, we discuss factors influencing patient adherence and persistence to NOACs and possible problem solving strategies, especially involving an integrated care management, aiming for the improvement in patient outcomes and treatment satisfaction.
format Online
Article
Text
id pubmed-8850710
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-88507102022-02-17 Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation Farinha, José Maria Jones, Ian D Lip, Gregory Y H Eur Heart J Suppl Supplement Papers Atrial fibrillation (AF) is associated with an increased risk of stroke, which can be prevented by the use of oral anticoagulation. Although non-vitamin K antagonist oral anticoagulants (NOACs) have become the first choice for stroke prevention in the majority of patients with non-valvular AF, adherence and persistence to these medications remain suboptimal, which may translate into poor health outcomes and increased healthcare costs. Factors influencing adherence and persistence have been suggested to be patient-related, physician-related, and healthcare system-related. In this review, we discuss factors influencing patient adherence and persistence to NOACs and possible problem solving strategies, especially involving an integrated care management, aiming for the improvement in patient outcomes and treatment satisfaction. Oxford University Press 2022-02-14 /pmc/articles/PMC8850710/ /pubmed/35185408 http://dx.doi.org/10.1093/eurheartj/suab152 Text en Published on behalf of the European Society of Cardiology. © The Author(s) 2022. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Supplement Papers
Farinha, José Maria
Jones, Ian D
Lip, Gregory Y H
Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation
title Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation
title_full Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation
title_fullStr Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation
title_full_unstemmed Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation
title_short Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation
title_sort optimizing adherence and persistence to non-vitamin k antagonist oral anticoagulant therapy in atrial fibrillation
topic Supplement Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850710/
https://www.ncbi.nlm.nih.gov/pubmed/35185408
http://dx.doi.org/10.1093/eurheartj/suab152
work_keys_str_mv AT farinhajosemaria optimizingadherenceandpersistencetononvitaminkantagonistoralanticoagulanttherapyinatrialfibrillation
AT jonesiand optimizingadherenceandpersistencetononvitaminkantagonistoralanticoagulanttherapyinatrialfibrillation
AT lipgregoryyh optimizingadherenceandpersistencetononvitaminkantagonistoralanticoagulanttherapyinatrialfibrillation